Celltrion Healthcare IPO Set To Benefit From Biosimilar Successes

 
• By Jung Won Shin

Amid Celltrion's string of biosimilar approvals and launches in the US and Europe, its marketing and distribution arm Celltrion Healthcare seems to have picked the perfect timing to launch an IPO.

US dollars

More from South Korea

More from Focus On Asia